Graviton Bioscience
Alexandra Zanin-Zhorov, PhD has an extensive background in immunology, with experience ranging from postdoctoral work to senior leadership positions in various pharmaceutical companies. Currently serving as the Senior Vice President of Translational Medicine at Graviton Bioscience, Alexandra has also held similar roles at Equilibre BioPharmaceuticals and Kadmon Pharmaceuticals, LLC. Alexandra's academic journey includes earning a Ph.D. in Immunology from The Weizmann Institute of Science, as well as obtaining Master's and Bachelor's degrees in Biology from Tel Aviv University.
Graviton Bioscience
Graviton Bioscience, a privately held clinical-stage biotechnology company focused on therapies that inhibit Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2), along with other therapeutic compounds.